Study of the Use of Permethrin 5% Cream in Galicia (Spain) between 2018 and 2021
Abstract
1. Introduction
2. Materials and Methods
3. Results and Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Salavastru, C.M.; Chosidow, O.; Boffa, M.J.; Janier, M.; Tiplica, G.S. European guideline for the management of scabies. J. Eur. Acad. Dermatol. Venereol. 2017, 31, 1248–1253. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Thomas, C.; Coates, S.J.; Engelman, D.; Chosidow, O.; Chang, A.Y. Part I—Ectoparasites: Scabies. J. Am. Acad. Dermatol. 2019, 82, 533–548. [Google Scholar] [CrossRef] [PubMed]
- Welch, E.; Romani, L.; Whitfeld, M.J. Recent advances in understanding and treating scabies. Fac. Rev. 2021, 10, 28. [Google Scholar] [CrossRef]
- Tarbox, M.; Walker, K.; Tan, M. Scabies. JAMA 2018, 320, 612. [Google Scholar] [CrossRef]
- Chosidow, O. Clinical practices. Scabies. N. Engl. J. Med. 2006, 354, 1718–1727. [Google Scholar] [CrossRef] [PubMed]
- Hernández, R.V.; González, M.E.R.; Polar, E.O.; del Tánago, P.G.G.; Carlavilla, F.J.P. Enfermedades de transmisión sexual (ETS). Panorama Actual. Med. 2018, 42, 417–424. [Google Scholar]
- Nowowiejska, J.; Król, M.E.; Dluzniewska, P.; Olszynka, M.; Baran, A.; Flisiak, I. Scabies—Still current medical and social problem. A retrospective analysis of 193 cases. Przegl. Epidemiol. 2019, 73, 19–29. [Google Scholar] [CrossRef]
- Casals, M. Sarna: Una epidemia dentro de una pandemia [Scabies: An epidemic within a pandemic]. Piel 2021, 36, 281–283. [Google Scholar] [CrossRef]
- Aždajić, M.D.; Bešlić, I.; Gašić, A.; Ferara, N.; Pedić, L.; Lugović-Mihić, L. Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show? Life 2022, 12, 1598. [Google Scholar] [CrossRef]
- Skayem, C.; Majda, A.; Gary, C.; Hemery, F.; Mahé, E.; Caux, F.; Dupin, N.; Senet, P.; Greder-Belan, A.; Hillion, B.; et al. Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature. Acta Derm. Venereol. 2023, 103, adv00878. [Google Scholar] [CrossRef]
- Moriano, C.F. Salud sexual. Panor. Actual. Med. 2019, 420, 4–32. [Google Scholar]
- Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Guideline for the diagnosis and treatment of scabies in Japan (third edition). J. Dermatol. 2017, 44, 991–1014. [Google Scholar] [CrossRef]
- SSunderkötter, C.; Feldmeier, H.; Fölster-Holst, R.; Geisel, B.; Klinke-Rehbein, S.; Nast, A.; Philipp, S.; Sachs, B.; Stingl, J.; Stoevesandt, J.; et al. S1 guidelines on the diagnosis and treatment of scabies—Short version. J. Dtsch. Dermatol. Ges. 2016, 14, 1155–1167. [Google Scholar] [CrossRef]
- Redondo-Bravo, L.; Fernandez-Martinez, B.; Gómez-Barroso, D.; Gherasim, A.; García-Gómez, M.; Benito, A.; Herrador, Z. Scabies in Spain? A comprehensive epidemiological picture. PLoS ONE 2021, 16, e0258780. [Google Scholar] [CrossRef] [PubMed]
- Figueiras, A.; Caamano, F.; Gestal Otero, J. Metodología de los estudios de utilización de medicamentos en atención primaria. Gac. Sanit. 2000, 14, 7–19. [Google Scholar]
- Vázquez-Prieto, S.; Vaamonde, A.; Paniagua, E. Study of the Use of Antinematode Drugs, Mebendazole and Pyrantel, in Galicia (Spain) from 2016 to 2020. J. Parasitol. Res. 2022, 13, 7792006. [Google Scholar] [CrossRef]
- Capellá, D.; Laporte, J.R. Métodos Aplicados en Estudios Descriptivos de Utilización de Medicamentos. In Principios de Epidemiología del Medicamento, 1st ed.; Laporte, J.R., Tognoni, G., Eds.; Masson-Salvat: Barcelona, Spain, 1993; pp. 67–94. [Google Scholar]
- Instituto Gallego de Estadística. Available online: https://www.ige.eu/igebdt/selector.jsp?COD=590&paxina=001&c=0201001002. (accessed on 1 October 2022).
- Mumcuoglu, K.Y.; Hoffman, T.; Schwartz, E. Scabicide sales before and during the COVID-19 epidemic in Israel. New Microbes New Infect. 2023, 51, 101074. [Google Scholar] [CrossRef]
- Isoletta, E.; Vassallo, C.; Brazzelli, V.; Giorgini, C.; Tomasini, C.F.; Sabena, A.; Perlini, S.; De Silvestri, A.; Barruscotti, S. Emergency accesses in Dermatology Department during the COVID-19 pandemic in a referral third level center in the north of Italy. Dermatol Ther. 2020, 33, e14027. [Google Scholar] [CrossRef]
- Martínez-Pallás, I.; Aldea-Manrique, B.; Ramírez-Lluch, M.; Vinuesa-Hernando, J.M.; Ara-Martín, M. Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic. J. Eur. Acad. Dermatol. Venereol. 2020, 34, e781–e783. [Google Scholar] [CrossRef]
- Herzum, A.; Gariazzo, L.; Viglizzo, G.; Garibeh, E.; Pastorino, C.; Occella, C. A resistant parasitic flare-up amid children in Italy: Comment on “Diagnosis and management of pediatric scabies: Results from a survey on 317 Italian dermatologists”. Travel Med. Infect. Dis. 2023, 52, 102545. [Google Scholar] [CrossRef]
- Mimouni, D.; Ankol, O.E.; Davidovitch, N.; Gdalevich, M.; Zangvil, E.; Grotto, I. Seasonality trends of scabies in a young adult population: A 20-year follow-up. Br. J. Dermatol. 2003, 149, 157–159. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.M.; Wang, H.W.; Chang, F.W.; Liu, Y.P.; Chiu, F.H.; Lin, Y.C.; Cheng, K.C.; Hsu, R.J. The effects of climate factors on scabies. A 14-year population-based study in Taiwan. Parasite 2016, 23, 54. [Google Scholar] [CrossRef] [PubMed]
- Engelman, D.; Yoshizumi, J.; Hay, R.J.; Osti, M.; Micali, G.; Norton, S.; Walton, S.; Boralevi, F.; Bernigaud, C.; Bowen, A.; et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br. J. Dermatol. 2020, 183, 808–820. [Google Scholar] [CrossRef][Green Version]
- Morgado-Carrasco, D.; Piquero-Casals, J.; Podlipnik, S. Tratamiento de la escabiosis [Treatment of scabies]. Aten Primaria. 2022, 54, 102231. [Google Scholar] [CrossRef]
- Nemecek, R.; Stockbauer, A.; Lexa, M.; Poeppl, W.; Mooseder, G. Application errors associated with topical treatment of scabies: An observational study. J. Dtsch. Dermatol. Ges. 2020, 18, 554–559. [Google Scholar] [CrossRef] [PubMed]
- Lluch-Galcerá, J.J.; Carrascosa, J.M.; Boada, A. Epidemic Scabies: New Treatment Challenges in an Ancient Disease. Actas Dermosifiliogr. 2022, 11, S0001-7310. [Google Scholar]
- Velasco-Amador, J.P.; Prados-Carmona, A.; Ruiz-Villaverde, R. RF—Resistance to Permethrin in Scabies Treatment: Does It Really Exist? Actas Dermosifiliogr. 2022; S0001-7310, in press. [Google Scholar]
- Sunderkötter, C.; Aebischer, A.; Neufeld, M.; Löser, C.; Kreuter, A.; Bialek, R.; Hamm, H.; Feldmeier, H. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J. Dtsch. Dermatol. Ges. 2019, 1, 15–23. [Google Scholar] [CrossRef][Green Version]
- Meyersburg, D.; Kaiser, A.; Bauer, J.W. Loss of efficacy of topical 5% permethrin for treating scabies: An Austrian single-center study. J. Dermatolog. Treat. 2022, 33, 774–777. [Google Scholar] [CrossRef]
- Mazzatenta, C.; Piccolo, V.; Argenziano, G.; Bassi, A. Is Scabies becoming less sensitive to permethrin therapy? J. Eur. Acad. Dermatol. Venereol. 2021, 35, e607-9. [Google Scholar] [CrossRef]
- Balestri, R.; Magnano, M.; Infusino, S.D.; Rizzoli, L.; Girardelli, C.R.; Rech, G. Scabies is becoming less sensitive to permethrin therapy. J. Eur. Acad. Dermatol. Venereol. 2021, 35, e889–e891. [Google Scholar] [CrossRef] [PubMed]
- Bassi, A.; Mazzatenta, C.; Piccolo, V. Diagnosis and management of pediatric scabies: Results from a survey on 317 Italian dermatologists. Travel Med. Infect. Dis. 2022, 50, 102461. [Google Scholar] [CrossRef] [PubMed]
- Walton, S.F.; Myerscough, M.R.; Currie, B.J. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc. Trop. Med. Hyg. 2000, 94, 92–96. [Google Scholar] [CrossRef] [PubMed]
- Khalil, S.; Abbas, O.; Kibbi, A.G.; Kurban, M. Scabies in the age of increasing drug resistance. PLoS Negl. Trop. Dis. 2017, 11, e0005920. [Google Scholar] [CrossRef][Green Version]
Mean DID | 95% CI | |
---|---|---|
A CORUÑA | 0.967 | 0.860, 1.074 |
LUGO | 1.168 | 1.087, 1.250 |
OURENSE | 1.279 | 1.177, 1.381 |
PONTEVEDRA | 1.377 | 1.245, 1.510 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vázquez-Prieto, S.; Vaamonde, A.; Paniagua, E. Study of the Use of Permethrin 5% Cream in Galicia (Spain) between 2018 and 2021. Infect. Dis. Rep. 2023, 15, 222-230. https://doi.org/10.3390/idr15020023
Vázquez-Prieto S, Vaamonde A, Paniagua E. Study of the Use of Permethrin 5% Cream in Galicia (Spain) between 2018 and 2021. Infectious Disease Reports. 2023; 15(2):222-230. https://doi.org/10.3390/idr15020023
Chicago/Turabian StyleVázquez-Prieto, Severo, Antonio Vaamonde, and Esperanza Paniagua. 2023. "Study of the Use of Permethrin 5% Cream in Galicia (Spain) between 2018 and 2021" Infectious Disease Reports 15, no. 2: 222-230. https://doi.org/10.3390/idr15020023
APA StyleVázquez-Prieto, S., Vaamonde, A., & Paniagua, E. (2023). Study of the Use of Permethrin 5% Cream in Galicia (Spain) between 2018 and 2021. Infectious Disease Reports, 15(2), 222-230. https://doi.org/10.3390/idr15020023